Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing

07:14 AM EDT, 09/28/2026 (MT Newswires) -- Jennifer Jarrett, Director, Director, President and Chief Executive Officer, on September 25, 2026, executed a purchase for 12,500 shares in Damora Therapeutics (DMRA) for $252,875. Following the Form 4 filing with the SEC, Jarrett has control over a total of 512,500 ordinary shares of the company, with 512,500 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800315/000119312526403355/xslF345X05/ownership.xml